Literature DB >> 18606696

Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection.

Mana Miyakoda1, Daisuke Kimura, Masao Yuda, Yasuo Chinzei, Yoshisada Shibata, Kiri Honma, Katsuyuki Yui.   

Abstract

Cerebral malaria is one of the severe complications of Plasmodium falciparum infection. Studies using a rodent model of Plasmodium berghei ANKA infection established that CD8(+) T cells are involved in the pathogenesis of cerebral malaria. However, it is unclear whether and how Plasmodium-specific CD8(+) T cells can be activated during the erythrocyte stage of malaria infection. We generated recombinant Plasmodium berghei ANKA expressing OVA (OVA-PbA) to investigate the parasite-specific T cell responses during malaria infection. Using this model system, we demonstrate two types of CD8(+) T cell activations during the infection with malaria parasite. Ag (OVA)-specific CD8(+) T cells were activated by TAP-dependent cross-presentation during infection with OVA-PbA leading to their expression of an activation phenotype and granzyme B and the development to functional CTL. These highly activated CD8(+) T cells were preferentially sequestered in the brain, although it was unclear whether these cells were involved in the pathogenesis of cerebral malaria. Activation of OVA-specific CD8(+) T cells in RAG2 knockout TCR-transgenic mice during infection with OVA-PbA did not have a protective role but rather was pathogenic to the host as shown by their higher parasitemia and earlier death when compared with RAG2 knockout mice. The OVA-specific CD8(+) T cells, however, were also activated during infection with wild-type parasites in an Ag-nonspecific manner, although the levels of activation were much lower. This nonspecific activation occurred in a TAP-independent manner, appeared to require NK cells, and was not by itself pathogenic to the host.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606696     DOI: 10.4049/jimmunol.181.2.1420

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Perforin Expression by CD8 T Cells Is Sufficient To Cause Fatal Brain Edema during Experimental Cerebral Malaria.

Authors:  Matthew A Huggins; Holly L Johnson; Fang Jin; Aurelie N Songo; Lisa M Hanson; Stephanie J LaFrance; Noah S Butler; John T Harty; Aaron J Johnson
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

2.  Damage to the blood-brain barrier during experimental cerebral malaria results from synergistic effects of CD8+ T cells with different specificities.

Authors:  Chek Meng Poh; Shanshan W Howland; Gijsbert M Grotenbreg; Laurent Rénia
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

3.  Phenotypic and functional profiling of malaria-induced CD8 and CD4 T cells during blood-stage infection with Plasmodium yoelii.

Authors:  Anmol Chandele; Paushali Mukerjee; Gobardhan Das; Rafi Ahmed; Virander S Chauhan
Journal:  Immunology       Date:  2010-10-29       Impact factor: 7.397

4.  Development of a Novel CD4+ TCR Transgenic Line That Reveals a Dominant Role for CD8+ Dendritic Cells and CD40 Signaling in the Generation of Helper and CTL Responses to Blood-Stage Malaria.

Authors:  Daniel Fernandez-Ruiz; Lei Shong Lau; Nazanin Ghazanfari; Claerwen M Jones; Wei Yi Ng; Gayle M Davey; Dorothee Berthold; Lauren Holz; Yu Kato; Matthias H Enders; Ganchimeg Bayarsaikhan; Sanne H Hendriks; Lianne I M Lansink; Jessica A Engel; Megan S F Soon; Kylie R James; Anton Cozijnsen; Vanessa Mollard; Alessandro D Uboldi; Christopher J Tonkin; Tania F de Koning-Ward; Paul R Gilson; Tsuneyasu Kaisho; Ashraful Haque; Brendan S Crabb; Francis R Carbone; Geoffrey I McFadden; William R Heath
Journal:  J Immunol       Date:  2017-10-30       Impact factor: 5.422

5.  IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria.

Authors:  Jintao Guo; James A McQuillan; Belinda Yau; Gregory S Tullo; Carole A Long; Patrick Bertolino; Ben Roediger; Wolfgang Weninger; Gregory A Taylor; Nicholas H Hunt; Helen J Ball; Andrew J Mitchell
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

6.  Platelets present antigen in the context of MHC class I.

Authors:  Lesley M Chapman; Angela A Aggrey; David J Field; Kalyan Srivastava; Sara Ture; Katsuyuki Yui; David J Topham; William M Baldwin; Craig N Morrell
Journal:  J Immunol       Date:  2012-06-15       Impact factor: 5.422

Review 7.  Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.

Authors:  Sabrina Torre; David Langlais; Philippe Gros
Journal:  Mamm Genome       Date:  2018-06-19       Impact factor: 2.957

8.  Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA.

Authors:  Takahiko Tamura; Kazumi Kimura; Masao Yuda; Katsuyuki Yui
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

9.  Host immune response is severely compromised during lethal Plasmodium vinckei infection.

Authors:  Jyoti Bhardwaj; Arif Jamal Siddiqui; Manish Goyal; Kirtika Prakash; Awakash Soni; Sunil K Puri; Mrigank Srivastava
Journal:  Parasitol Res       Date:  2015-06-17       Impact factor: 2.289

10.  CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis.

Authors:  Mahmoud Nateghi Rostami; Hossein Keshavarz; Rosita Edalat; Abdolfattah Sarrafnejad; Tahereh Shahrestani; Fereidoun Mahboudi; Ali Khamesipour
Journal:  PLoS Negl Trop Dis       Date:  2010-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.